Vera Therapeutics Inc. (VERA) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	20.17K
Depreciation and amortization	296.81K
Increase in bad debt reserve	5.1K
Change in acquisition liabilities
Compensation expense - equity grants	22.02K
Loss on disposal of fixed assets
Accounts receivable	68.4K
Prepaid expenses and other current assets	-90.46K
Pension assets	-8.15K
Deposits and other assets	-586.69K
Accounts payable	166.11K
Accrued compensation	-207.47K
Deferred revenue	320.78K
Other accrued liabilities	521.79K
Note payable
Prepaid rent liability	36.04K
Pension obligation	-86.27K
Net cash provided (used) by operating activities	478.18K
Acquisition - cash paid	0
Sale of investments	0
Additions to property and equipment	-4.08K
Capitalized software development costs	-134.3K
Net cash flows used by investing activities	-138.38K
Borrowing (repayment) - line of credit
Bank borrowing - repayment of term loan	-16.67K
Exercise of stock options	25.92K
Employee stock purchase plan	22.3K
Net cash provided by financing activities	31.55K
Net change in cash and cash equivalents	371.35K
Cash and cash equivalents, beginning of year	1.2M
Cash and cash equivalents, end of quarter	1.57M
Income taxes paid	15.25K
Interest paid	892

Entities mentioned with VERA

View All Entities